REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 71 filers reported holding REVANCE THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 1.63 and the average weighting 1.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $28,448,440 | -43.0% | 1,124,000 | -27.5% | 0.07% | -44.2% |
Q1 2023 | $49,909,395 | +131.9% | 1,549,500 | +32.9% | 0.13% | +115.0% |
Q4 2022 | $21,518,822 | +57.0% | 1,165,700 | +129.7% | 0.06% | +50.0% |
Q3 2022 | $13,703,000 | +814.8% | 507,500 | +368.2% | 0.04% | +900.0% |
Q2 2022 | $1,498,000 | -7.8% | 108,400 | +67.8% | 0.00% | -20.0% |
Q3 2020 | $1,624,000 | +8.6% | 64,600 | +5.6% | 0.01% | +25.0% |
Q2 2020 | $1,495,000 | +103.7% | 61,200 | +23.4% | 0.00% | +33.3% |
Q1 2020 | $734,000 | +241.4% | 49,600 | +198.8% | 0.00% | +200.0% |
Q2 2019 | $215,000 | -62.3% | 16,600 | -54.1% | 0.00% | 0.0% |
Q1 2019 | $571,000 | +21.0% | 36,200 | +90.5% | 0.00% | 0.0% |
Q3 2018 | $472,000 | -58.4% | 19,000 | -54.0% | 0.00% | -66.7% |
Q2 2018 | $1,134,000 | +65.1% | 41,306 | +85.2% | 0.00% | +50.0% |
Q1 2018 | $687,000 | +100.3% | 22,300 | +132.3% | 0.00% | +100.0% |
Q4 2017 | $343,000 | +9.6% | 9,600 | -2.0% | 0.00% | -50.0% |
Q2 2015 | $313,000 | -43.0% | 9,800 | -63.0% | 0.00% | -50.0% |
Q1 2015 | $549,000 | – | 26,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 4,415,689 | $86,106,000 | 6.66% |
Evolutionary Tree Capital Management, LLC | 176,336 | $3,439,000 | 2.39% |
Essex Woodlands Management, Inc. | 457,085 | $8,913,000 | 2.16% |
HealthCor Management, L.P. | 1,423,425 | $27,757,000 | 1.85% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,112,325 | $21,690,000 | 0.86% |
Waypoint Capital Advisors, LLC | 53,989 | $1,016,000 | 0.60% |
Antara Capital LP | 679,600 | $13,252,000 | 0.40% |
Rhenman & Partners Asset Management AB | 198,358 | $3,868,000 | 0.38% |
Walleye Capital LLC | 505,701 | $9,861,000 | 0.26% |
Polar Capital Holdings Plc | 2,456,497 | $47,902,000 | 0.22% |